I-Sep
Blood-component separation devices for hospitals performing hemorrhagic or high-risk surgery
Highlights
- New on EvolcAdded 2026-10-30
About I-Sep
i-SEP develops and markets intraoperative autotransfusion technology that recovers and separates blood components, including red blood cells and platelets. Its same™ device is used in hemorrhagic or high-risk hemorrhagic surgery.
The company works with clinicians and hospitals on Patient Blood Management solutions, aiming to support patient blood recovery and simplify physicians’ workflows.
Founded in 2015, i-SEP is a French medtech headquartered in Nantes. Its same™ device received a CE mark in 2022 under the MDR 2017/745 framework.
Product: Intraoperative autotransfusion devices and related blood-component separation technology.
Jobs at I-Sep
Leadership
- Guillaume Laurent · CEOSource: company website
- Ludwig Magueur · Head of FinanceSource: company website
More health & medtech companies
I-Virtual
Video-based vital sign measurement API for wellness, insurance and connected-device companiesNew on EvolcIavc
Digital stroke-care coordination solutions for patients, healthcare professionals and hospitalsYoung companyNew on EvolcIdris Software
Pharmacy compounding software (EasyPrep) for pharmacies and magistral preparation labs in FranceNew on EvolcImagerie Carnot
Medical imaging centres in Saint-Max and Château-Salins near Nancy offering X-ray, ultrasound and mammography to patientsYoung companyNew on EvolcImplicity
Cloud platform for remote monitoring of cardiac implant data and alerts, used by electrophysiology practices and medical centersNew on EvolcInato
AI-powered clinical trial platform connecting pharmaceutical sponsors, research sites and patientsRemote-friendlySalary transparent
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- Google reCAPTCHA
- WordPress
- jQuery